Literature DB >> 24827553

Establishment of a healthy human range for the whole blood "OX40" assay for the detection of antigen-specific CD4+ T cells by flow cytometry.

Ross Sadler1, Elizabeth A L Bateman, Victoria Heath, Smita Y Patel, Phillip P Schwingshackl, Alice C Cullinane, Lisa Ayers, Berne L Ferry.   

Abstract

BACKGROUND: Clinical investigation of antigen-specific T cells in potentially immunodeficient patients is an important and often challenging aspect of patient diagnostic work up. Methods for detection of microbial exposure to the T-cell compartment exist but are laborious and time consuming. Recently, a whole blood technique involving flow cytometry and detection of CD25 and OX40 (CD134) expression on the surface of activated CD4+ T cells was shown to be accurate and concordant when compared with more traditional methods of antigen-specific T-cell detection.
METHODS: Whole heparinized blood was collected from healthy donors and set up using the "OX40" assay to detect antigen-specific CD4+ T-cell responses to Varicella Zoster Virus, Epstein-Barr Virus (EBV), Cytomegalovirus, Candida albicans, and Streptococcus pneumoniae.
RESULTS: The "OX40" assay technique was clinically validated for routine use in an NHS clinical immunology laboratory by analysis of incubation length (40-50 h), sample transport time (up to 24 h at room temperature), concordance with serology testing, proliferation and interferon-gamma production. In addition, 63 healthy controls (age range 21-78) were tested for responses to generate a healthy control reference range.
CONCLUSIONS: The OX40 assay, as presented in this report, represents an economical, rapid, robust whole blood technique to detect antigen-specific T cells, which is suitable for clinical immunology diagnostic laboratory use.
© 2014 Clinical Cytometry Society.

Entities:  

Keywords:  CD4+ T cells; costimulation/costimulatory; diagnostics; flow cytometry

Mesh:

Substances:

Year:  2014        PMID: 24827553     DOI: 10.1002/cyto.b.21165

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  6 in total

1.  Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification.

Authors:  Patricio Escalante; Tobias Peikert; Virginia P Van Keulen; Courtney L Erskine; Cathy L Bornhorst; Boleyn R Andrist; Kevin McCoy; Larry R Pease; Roshini S Abraham; Keith L Knutson; Hirohito Kita; Adam G Schrum; Andrew H Limper
Journal:  Am J Respir Crit Care Med       Date:  2015-09-01       Impact factor: 21.405

2.  A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood.

Authors:  Jennifer M Dan; Cecilia S Lindestam Arlehamn; Daniela Weiskopf; Ricardo da Silva Antunes; Colin Havenar-Daughton; Samantha M Reiss; Matthew Brigger; Marcella Bothwell; Alessandro Sette; Shane Crotty
Journal:  J Immunol       Date:  2016-06-24       Impact factor: 5.422

3.  OX40 expression in neutrophils promotes hepatic ischemia/reperfusion injury.

Authors:  Hua Jin; Chunpan Zhang; Chengyang Sun; Xinyan Zhao; Dan Tian; Wen Shi; Yue Tian; Kai Liu; Guangyong Sun; Hufeng Xu; Dong Zhang
Journal:  JCI Insight       Date:  2019-11-01

Review 4.  OX40, OX40L and Autoimmunity: a Comprehensive Review.

Authors:  Gwilym J Webb; Gideon M Hirschfield; Peter J L Lane
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

Review 5.  Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors.

Authors:  Daniele E Mascarelli; Rhubia S M Rosa; Jessica M Toscaro; Isadora F Semionatto; Luciana P Ruas; Carolinne T Fogagnolo; Gabriel C Lima; Marcio C Bajgelman
Journal:  Front Cell Dev Biol       Date:  2021-06-30

6.  A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea - dose optimization, clinical outcomes, and CD4+ T cell responses.

Authors:  Sunniva Todnem Sakkestad; Hans Steinsland; Steinar Skrede; Kristine Lillebø; Dag Harald Skutlaberg; Anne Berit Guttormsen; Anton Zavialov; Sari Paavilainen; Hanne Søyland; Marianne Sævik; Astrid Rykkje Heien; Marit Gjerde Tellevik; Eileen Barry; Nina Langeland; Halvor Sommerfelt; Kurt Hanevik
Journal:  PLoS Negl Trop Dis       Date:  2019-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.